Shu-Ning Wei
Overview
Explore the profile of Shu-Ning Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
7
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song Y, Gong X, Wei S, Li Q, Zhang G, Wang Y, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2023 Apr;
31(2):352-357.
PMID: 37096505
Objective: To analyze the characteristics and prognosis of acute leukemia(AL) with fusion gene. Methods: The clinical data of 17 patients over 14 years old newly diagnosed with positive AL admitted...
2.
Li Y, Liu K, Gong B, Wang Y, Wei H, Lin D, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2020 Feb;
28(1):1-6.
PMID: 32027244
Objective: To investigate the efficacy and safety of arsenic trioxide combined with ATRA and chemo- therapy for treatment of relapsed acute promyelocytic leukemia (APL) patients. Methods: The clinic data of...
3.
Gong B, Lin D, Wei H, Wang Y, Liu B, Zhou C, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2018 Oct;
26(5):1269-1274.
PMID: 30295237
Objective: To evaluate the efficacy of primary prophylaxis of voriconazole against invasive infection of pulmonary aspergillosis (IPA) during remission-induction chemotherapy (RIC) of patients with acute myeloid leukemia (AML). Methods: Clinical...
4.
Gong B, Wang Y, Lin D, Wei H, Li W, Zhou C, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2016 Dec;
24(6):1615-1621.
PMID: 28024465
Objective: To evaluate the influence of FLT3-ITD mutation on long term survival of newly diagnosed patients with acute promyelocytic leukemia (APL). Methods: Long term survival of 170 newly diagnosed APL...
5.
Zhao X, Wei S, Liu K, Lin D, Wei H, Wang Y, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2015 May;
23(2):396-400.
PMID: 25948192
Objective: To evaluate the efficacy and safety of MAC regimen in the treatment of acute myeloid leukemia(AML) patients older than 55 years. Methods: A total of 33 relapsed or non-remission...
6.
Yuan Y, Li W, Lin D, Mi Y, Wang Y, Wei H, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2012 Feb;
32(11):752-7.
PMID: 22339911
Objective: To assess complete remission (CR), the overall survival (OS), event-free survival (EFS) and adverse events of newly diagnosed acute promyelocytic leukemia (APL) with homoharringtonine (HHT) plus ATRA, to evaluate...
7.
Wang S, Wei S, Qi J, Liu X, Yang H, Zhao J, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2012 Feb;
32(8):533-6.
PMID: 22338176
Objective: To investigate clinical and laboratory characteristics of acute myeloid leukemia (AML) patients with t(7;11)(p15;p15). Methods: Eleven patients with t(7;11)(p15;p15) were retrospectively reviewed involved in cell morphology, immunophenotype, cytogenetics as...
8.
Wei S, Wei H, Mi Y, Liu B, Liu K, Zhou C, et al.
Zhonghua Xue Ye Xue Za Zhi
. 2011 Mar;
32(1):8-11.
PMID: 21429393
Objective: To explore the safety and efficacy of sorafenib in combination with chemotherapy for the treatment of FLT3 positive acute myeloid leukemia (AML), to highlight the impact of FLT3 mutations...